ABLIM1 Knockout HT29 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal population of HT29 colorectal adenocarcinoma cells bearing targeted disruption of the ABLIM1 gene. This heterogeneous knockout pool avoids clonal artifacts and enables population-level loss-of-function studies. The polyclonal format recapitulates diverse editing outcomes and is suitable for bulk assays assessing overall pathway responses. As a ready-to-use research tool, it facilitates investigation of ABLIM1-dependent tumor suppression and cytoskeletal regulation in colorectal cancer models.
The HT29 line was established from a primary colorectal adenocarcinoma of a 44-year-old female and displays adherent epithelial morphology. HT29 cells carry mutations in APC and ??-catenin that drive constitutive Wnt signaling, making them highly relevant for cancer research. Widely used as an intestinal epithelial model, these cells provide a robust platform for examining colorectal cancer biology, including tumor progression and metastasis, due to their well-characterized proliferative and invasive properties.
ABLIM1 encodes an actin-binding LIM domain protein that stabilizes actin filaments and regulates cell adhesion and migration. It interacts with F-actin, ??-catenin, and ??-actinin, and its expression is controlled by Wnt-responsive TCF/LEF transcription factors and epigenetic silencing via promoter methylation. Loss of ABLIM1 relieves tumor-suppressive constraints, potentially enhancing Wnt/??-catenin signaling and cytoskeletal reorganization. Downstream effects involve actin remodeling, vinculin, paxillin, and the cell migration machinery, coordinated by Rho GTPases, ROCK, LIM kinase, and cofilin. This positions ABLIM1 at the intersection of cell adhesion and oncogenic signaling.
In HT29 cells, ABLIM1 knockout is particularly valuable for dissecting colorectal cancer metastasis and tumor progression. ABLIM1 loss can destabilize actin networks and adhesions, promoting a migratory phenotype and potentially enhancing epithelial-mesenchymal transition (EMT). The model allows direct examination of how ABLIM1 disruption influences Wnt and Hippo pathway interplay, affecting ??-catenin shuttling and stress fiber formation. This provides a system to study actin-binding proteins in cancer cell dissemination and to identify therapeutic targets within cytoskeletal networks.
Typical applications include western blotting for ABLIM1, ??-catenin, and actin; Transwell migration and invasion assays; and immunofluorescence imaging of actin cytoskeleton reorganization. Wnt reporter assays permit monitoring of transcriptional activity, while cell proliferation assays assess growth phenotypes. The knockout population also serves as a tool for drug screening aimed at restoring tumor suppression or inhibiting cytoskeletal dysregulation in colorectal cancer. For additional information or technical support, please contact Ascent Research.
